IMV Inc. (IMV:NASDAQ) soared at $4.63, representing a gain of 54.3%. The stock got featured on our News Catalysts scanner on Tue 14 Jul 20 at 02:19 PM in the 'BIOTECH' category. From Mon 29 Jun 20, the stock recorded 33.33% Up Days and 30.00% Green Days
The stock spiked on Thu 21 May 20 at $4 with a volume of 2M+, and its share price has been moving sideways in recent weeks.
About IMV Inc. (IMV:NASDAQ)
Immunovaccine Inc is a Canada based clinical-stage biopharmaceutical company. Through its subsidiary, the firm develops T cell activating cancer immunotherapies and infectious disease vaccines based on DepoVax.
Top 10 Gainers:
- Perceptron, Inc. (PRCP:NASDAQ), 107.01%
- Rigel Pharmaceuticals, Inc. (RIGL:NASDAQ), 90.97%
- INmune Bio, Inc. (INMB:NASDAQ), 77.97%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 57.21%
- IMV Inc. (IMV:NASDAQ), 54.33%
- Dare Bioscience, Inc. (DARE:NASDAQ), 50.5%
- Vaxart, Inc. (VXRT:NASDAQ), 40.02%
- Caladrius Biosciences, Inc. (CLBS:NASDAQ), 38.89%
- Iconix Brand Group, Inc. (ICON:NASDAQ), 33.33%
- VIVUS, Inc. (VVUS:NASDAQ), 32.45%